Suspected Drug-Associated Coronary Vasospasm With Transient ST-Segment Elevation During Multi-Agent Chemotherapy in a Patient With Gastric Cancer: A Case Report

Objective:Unusual clinical course Background:Fluorouracil (5-FU) can induce coronary vasospasm that mimics ST-segment elevation myocardial infarction.During multi-agent chemotherapy, attribution to a single agent is difficult.This case illustrates diagnostic uncertainty when transient ST-segment elevation resolves with vasodilators and coronary evaluation is deferred. Case Report:A 71-year-old man with locally advanced gastric adenocarcinoma presented with intermittent chest pain 2 days after starting cycle 1 of 5-FU, oxaliplatin, docetaxel, and durvalumab.The initial electrocardiogram showed mild lateral ST-segment depression.Approximately 2 hours later, severe chest pain developed with ST-segment elevation in V2-V6 and II, III, and aVF.Pain and ST-segment elevation resolved within approximately 45 minutes of intravenous diltiazem and nitroglycerin, and planned cardiac catheterization was not performed.High-sensitivity troponin values were 27, 44, and 55 ng/L on Day 0 and 16 ng/L on Day 5; no intervening measurements were obtained, and the peak was not captured.Echocardiography showed an ejection fraction of 57% without wall motion abnormalities.Computed tomography pulmonary angiography excluded pulmonary embolism.Coronary angiography, coronary computed tomography angiography, stress testing, and cardiac magnetic resonance imaging were not performed.No chest pain recurred during approximately 1 week of follow-up on isosorbide mononitrate and amlodipine. Conclusions:Transient ST-segment elevation during multi-agent chemotherapy can reflect drug-associated coronary vasospasm.However, in the present case, obstructive coronary disease, thrombotic acute coronary syndrome, and immune checkpoint inhibitor myocarditis were not excluded, and no single agent could be implicated.Resolution with vasodilators did not establish the diagnosis.Deferring coronary evaluation was a case-specific decision, not a recommended approach.

Authors

Institutions

Publication Details

Journal
American Journal of Case Reports
Published
2026-11-06
DOI
https://doi.org/10.12659/ajcr.955231
Primary Topic
Chemotherapy-induced cardiotoxicity and mitigation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Suspected Drug-Associated Coronary Vasospasm With Transient ST-Segment Elevation During Multi-Agent Chemotherapy in a Patient With Gastric Cancer: A Case Report

Saundra A. Jackson, Michael Mohseni, Charles Graham, Richard Courtney
American Journal of Case Reports
Chemotherapy-induced cardiotoxicity and mitigation
article

Suspected Drug-Associated Coronary Vasospasm With Transient ST-Segment Elevation During Multi-Agent Chemotherapy in a Patient With Gastric Cancer: A Case Report

Saundra A. Jackson, Michael Mohseni, Charles Graham, Richard Courtney
article en

Abstract

Objective:Unusual clinical course Background:Fluorouracil (5-FU) can induce coronary vasospasm that mimics ST-segment elevation myocardial infarction.During multi-agent chemotherapy, attribution to a single agent is difficult.This case illustrates diagnostic uncertainty when transient ST-segment elevation resolves with vasodilators and coronary evaluation is deferred. Case Report:A 71-year-old man with locally advanced gastric adenocarcinoma presented with intermittent chest pain 2 days after starting cycle 1 of 5-FU, oxaliplatin, docetaxel, and durvalumab.The initial electrocardiogram showed mild lateral ST-segment depression.Approximately 2 hours later, severe chest pain developed with ST-segment elevation in V2-V6 and II, III, and aVF.Pain and ST-segment elevation resolved within approximately 45 minutes of intravenous diltiazem and nitroglycerin, and planned cardiac catheterization was not performed.High-sensitivity troponin values were 27, 44, and 55 ng/L on Day 0 and 16 ng/L on Day 5; no intervening measurements were obtained, and the peak was not captured.Echocardiography showed an ejection fraction of 57% without wall motion abnormalities.Computed tomography pulmonary angiography excluded pulmonary embolism.Coronary angiography, coronary computed tomography angiography, stress testing, and cardiac magnetic resonance imaging were not performed.No chest pain recurred during approximately 1 week of follow-up on isosorbide mononitrate and amlodipine. Conclusions:Transient ST-segment elevation during multi-agent chemotherapy can reflect drug-associated coronary vasospasm.However, in the present case, obstructive coronary disease, thrombotic acute coronary syndrome, and immune checkpoint inhibitor myocarditis were not excluded, and no single agent could be implicated.Resolution with vasodilators did not establish the diagnosis.Deferring coronary evaluation was a case-specific decision, not a recommended approach.

American Journal of Case ReportsVol. 27
Mayo Clinic in Florida (US)
Good health and well-being
Openalex Percentile: Top 13%
Chemotherapy-induced cardiotoxicity and mitigation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon